Publication Ethics and Permissions
Publication Ethics & Permissions
Publication Ethics
At Global Diagnostics and Therapeutics in Medicine is committed to upholding the highest ethical standards in its editorial operations. We follow the Code of Conduct and Best Practice Guidelines set by the Committee on Publication Ethics (COPE) and the recommendations of the World Association of Medical Editors (WAME).
To maintain research integrity, we use plagiarism detection software and adhere to COPE guidelines for managing any instances of plagiarism. We are dedicated to investigating and addressing misconduct to uphold the reliability of the research we publish.
The Editor-in-Chief oversees the entire editorial process, ensuring compliance with COPE’s Ethical Oversight guidance and best practices. This comprehensive approach ensures that both the integrity of the research and the ethical treatment of research subjects are maintained.
Permission For Use Of Article Content
Articles published in Global Diagnostics and Therapeutics in Medicine are made available under specific Creative Commons licenses. Depending on the author’s choice, the content may be licensed under the CC BY-NC-ND (Creative Commons Attribution Non-Commercial No Derivatives 4.0 International) license, which allows others to share the content for non-commercial purposes, provided that the authors are properly credited. Commercial use or any modifications require additional permission. Alternatively, the content may be licensed under the CC BY (Creative Commons Attribution 4.0 International) license, which permits sharing, adaptation, and commercial use, as long as proper credit is given to the authors.
By submitting their work to Global Diagnostics and Therapeutics in Medicine, authors agree to the application of these licenses, thereby granting certain rights to the public. This includes allowing others to reuse their work in accordance with the license terms, such as redistribution, copying, or adaptation, depending on the specific license chosen. However, the authors retain the right to be credited for their original work. These licenses are designed to support the broad dissemination of research while ensuring proper attribution and compliance with licensing terms.
Compliance With NIH and Other Funding Agencies
Global Diagnostics and Therapeutics in Medicine is committed to helping authors meet the open access requirements of their funding agencies. Many funders require public access to peer-reviewed research, typically through deposit of the Author Accepted Manuscript (AAM), the version accepted after peer review but before final journal formatting — in public repositories.
To support compliance, we provide the following options
U.S. government and NIH-funded research: For articles arising from U.S. federal funding, including NIH, Global Diagnostics and Therapeutics in Medicine will deposit the Author Accepted Manuscript in PubMed Central. The manuscript will be made publicly available after publication under the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND 4.0) license.
Authors funded by non-profit organizations with open access mandates: For authors supported by organizations such as Coalition S, Wellcome Trust, UKRI, or NIHR, the Author Accepted Manuscript may be deposited in PubMed Central or Europe PMC following publication. If the funder requires a Creative Commons Attribution (CC BY 4.0) license, Global Diagnostics and Therapeutics in Medicine will honor that request.
All other authors: Authors whose funders do not mandate a specific license may deposit the Author Accepted Manuscript in a non-commercial repository after publication, under the CC BY-NC-ND 4.0 license. This version must include a link to the final Version of Record on the Global Diagnostics and Therapeutics in Medicine website.
Pre-Print Policy
Manuscripts previously posted on a preprint server are eligible for submission. Authors must include details about the preprint when submitting the manuscript, including a link to the preprint and a description of any revisions or differences between the submitted manuscript and the preprint.
Embargo Policy
Authors must not disclose their manuscript’s acceptance to anyone except coauthors and contributors until it is published. All details about the content and publication date are confidential. Unauthorized prepublication release of this information may lead to the manuscript’s acceptance being revoked. This policy applies to all article types.
Website Content and Branding Permissions
Criteria For Evaluating Manuscripts
All non-article content on the Global Diagnostics and Therapeutics in Medicine website, including design, layout, graphics, logos, images, and branding elements, is copyrighted and proprietary to Global Diagnostics and Therapeutics in Medicine and its publisher. The journal’s name, logo, and associated branding are registered trademarks and may not be copied, distributed, transmitted, or used in any form without prior written permission, including for promotional, commercial, or endorsement purposes.
Permission To Use Content
Requests to copy or reuse content from Global Diagnostics and Therapeutics in Medicine may be granted under specific conditions, primarily for non-commercial educational or scholarly purposes.
Permission will Not be Granted for:
Any use of the journal’s name, logo, or branding without explicit written approval
Copying journal content to endorse or promote any product, service, or organization
Copying an entire publication, issue, or a substantial portion of journal content
Use of materials that have been withdrawn, retracted, or are under revision
Requesting Permission
To request permission to use or copy copyrighted materials, please email at global.diagnostics@journalmail.com
Permission will not be Granted for:
Any use of the journal’s name, logo, or branding without explicit written approval
Copying journal content to endorse or promote any product, service, or organization
Copying an entire publication, issue, or a substantial portion of journal content
Use of materials that have been withdrawn, retracted, or are under revision